We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marsh (MRSH) Surges 3.3%: Is This an Indication of Further Gains?
Read MoreHide Full Article
Marsh (MRSH - Free Report) shares rallied 3.3% in the last trading session to close at $176.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.5% loss over the past four weeks.
Shares of the company rose as its Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management. The deal also positions Madrid as a key hub, strengthening its presence across Europe and Latin America while supporting its push into global private markets and long-term growth.
This global professional services firm providing strategy, risk and people solutions is expected to post quarterly earnings of $3.22 per share in its upcoming report, which represents a year-over-year change of +5.2%. Revenues are expected to be $7.39 billion, up 4.6% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Marsh, the consensus EPS estimate for the quarter has been revised 0.7% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on MRSH going forward to see if this recent jump can turn into more strength down the road.
Marsh belongs to the Zacks Business - Services industry. Another stock from the same industry, AMN Healthcare Services (AMN - Free Report) , closed the last trading session 1.6% lower at $18.01. Over the past month, AMN has returned 6%.
For AMN Healthcare, the consensus EPS estimate for the upcoming report has changed +2238.1% over the past month to $1.64. This represents a change of +264.4% from what the company reported a year ago. AMN Healthcare currently has a Zacks Rank of #3 (Hold).
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Marsh (MRSH) Surges 3.3%: Is This an Indication of Further Gains?
Marsh (MRSH - Free Report) shares rallied 3.3% in the last trading session to close at $176.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.5% loss over the past four weeks.
Shares of the company rose as its Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management. The deal also positions Madrid as a key hub, strengthening its presence across Europe and Latin America while supporting its push into global private markets and long-term growth.
This global professional services firm providing strategy, risk and people solutions is expected to post quarterly earnings of $3.22 per share in its upcoming report, which represents a year-over-year change of +5.2%. Revenues are expected to be $7.39 billion, up 4.6% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Marsh, the consensus EPS estimate for the quarter has been revised 0.7% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on MRSH going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Marsh belongs to the Zacks Business - Services industry. Another stock from the same industry, AMN Healthcare Services (AMN - Free Report) , closed the last trading session 1.6% lower at $18.01. Over the past month, AMN has returned 6%.
For AMN Healthcare, the consensus EPS estimate for the upcoming report has changed +2238.1% over the past month to $1.64. This represents a change of +264.4% from what the company reported a year ago. AMN Healthcare currently has a Zacks Rank of #3 (Hold).